Merrimack Pharmaceuticals Aktie

5,27 $ +3,33% +0,17 $
In Euro: 4,9420 € | 02.12.16 Nasdaq | Mehr Kurse »
WKN: A1JHBG
ISIN: US5903281005
Symbol: MACK
Typ: Aktie

Performance Merrimack Pharmaceuticals Aktie

1 Woche 1 Monat 3 Monate Lfd. Jahr 1 Jahr 3 Jahre
Kurs 6,41 $ 5,37 $ 4,53 $ 7,90 $ 9,06 $ 4,20 $
Änderung -17,78% -1,86% +16,34% -33,29% -41,83% +25,48%

Forum zur Merrimack Pharmaceuticals Aktie

narbonne: Meldung
11.10.16
Disease control achieved in twice as many patients treated with ONIVYDE in combination with 5-FU and leucovorin (52%) compared to 5-FU and leucovorin alone (24%)To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-​releases/final-...
biotech1x1: News vom 24.03.2016
30.03.16
Merrimack Announces Inclusion of ONIVYDE® (irinotecan liposome injection) as a Category 1 Treatment Option in the 2016 NCCN Guidelines for Pancreatic Adenocarcinoma https://beta.finance.yahoo.com/news/merrimack-​announces-inclusion-onivyde-irinotecan-...

Aktie & Unternehmen

Branche Pharmazeutik
Herkunft USA
Website www.merrimack.com
Aktienanzahl 129,6 Mio. (Stand: 29.11.16)
Marktkap. 683,1 Mio. $

Dividenden & Splits

Keine Daten im genannten Zeitraum vorhanden

Ähnliche Aktien

Name
last
change_rel
 
KalVista Pharmaceuticals 7,472 € +0,97%
Dipexium Pharmaceuticals 1,267 € +3,60%
Cosmo Pharm 160,576 € -0,26%
Recro Pharma 6,00 € -0,48%
Aegerion Pharmaceuticals 1,729 € 0,00%